Andre Machado, MD, PhD, the new Chair of Cleveland Clinic’s Neurological Institute, kicked off Cleveland Clinic’s 13th Annual Medical Innovation Summit by sharing his vision for neuroscience innovation.Read More
A new multicenter study aims to clarify whether and when to consider zoster vaccination in patients taking anti-TNF therapies or other immune-modulating biologics.
After extensive preparation, Cleveland Clinic has broadened its urology nurse practitioners’ and physician assistants’ roles to allow them to provide care independent from physicians’ practices. The result is better patient access and higher job satisfaction.
A new combination epigenetic therapy could enhance activity of immune checkpoint inhibitors in lung cancer. A proof-of-concept trial of oral tetrahydrouridine (THU)-decitabine, along with nivolumab, will begin soon at Cleveland Clinic.
No one needs to tell Dr. Naim Alkhouri that invasive tests for nonalcoholic fatty liver disease are ill-suited to kids. His quest to find a noninvasive alternative has him exploring a host of promising options.
Physicians’ partnerships with industry can be beneficial to patients but the nuances of their relationships can be complex. These relationships must be evaluated closely and managed properly to maximize patient protections.
Recent findings in the mouse suggest that microglia’s protective role might be harnessed to improve prognoses across many neurologic diseases. The researchers explain their work and look ahead to next steps.
Robotic and catheter-based techniques promise to make mitral valve repair and replacement less invasive than ever. But how effective are they, and are robotic approaches ready to go mainstream?
From hourly rounding to safety checks, nurses at Medina Hospital are working together to reduce patient falls. A unique hands-on training approach is also helping with prevention.
Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas provides treatment options for Alzheimer’s disease patients and support for their caregivers.